Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Mesh.i » - entrée « Patient Selection »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Patient Safety < Patient Selection < Patient Simulation  Facettes :

List of bibliographic references indexed by Patient Selection

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000378 (2021) Melanie M. Taylor [États-Unis] ; Loulou Kobeissi [Suisse] ; Caron Kim [Suisse] ; Avni Amin [Suisse] ; Anna E. Thorson [Suisse] ; Nita B. Bellare [Suisse] ; Vanessa Brizuela [Suisse] ; Mercedes Bonet [Suisse] ; Edna Kara [Suisse] ; Soe Soe Thwin [Suisse] ; Hamsadvani Kuganantham [Suisse] ; Moazzam Ali [Suisse] ; Olufemi T. Oladapo [Suisse] ; Nathalie Broutet [Suisse]Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action.
000904 (2020) Migita D'Cruz [Inde]The ICMR bulletin on targeted hydroxychloroquine prophylaxis for Covid-19: Need to interpret with caution.
000A34 (2020) Kai KupferschmidtU.K. megatrial outshines other drug studies.
000A85 (2020) Tasnim I. Lat [États-Unis] ; Chhaya D. Patel [États-Unis] ; Jessica C. Ehrig [États-Unis] ; Conner Moslander [États-Unis] ; Juan F. Sanchez [États-Unis]Therapeutic options in the treatment of severe acute respiratory syndrome coronavirus 2 in pregnant patient.
000B24 (2020) Heidi LedfordThe coronavirus outbreak could make it quicker and easier to trial drugs.
000C37 (2020) David N. Juurlink [Canada]Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
000C91 (2020) Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan [Royaume-Uni] ; Olena Zimba [Ukraine]Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
000D72 (2020) Juliet Emamaullee [États-Unis] ; Michael Bowdish [États-Unis] ; Pui Yuk Yan [États-Unis] ; Valentina Rodina [États-Unis] ; Linda S. Sher [États-Unis]Rapid Adaptation of a Surgical Research Unit to Conduct Clinical Trials During the COVID-19 Pandemic.
000E57 (2020) Simin Dashti-Khavidaki [Iran] ; Hossein Khalili ; Anahid NourianPharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review.
001358 (2020) Catherine Knowlson [Royaume-Uni] ; David J. Torgerson [Royaume-Uni]Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial.
001440 (2020) Mehmet Soy [Turquie] ; Gökhan Keser [Turquie] ; Pamir Atagündüz [Turquie] ; Fehmi Tabak [Turquie] ; I K Atagündüz [Turquie] ; Servet Kayhan [Turquie]Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
001702 (2020) Sydney B. Ross [Canada] ; Marnie Goodwin Wilson [Canada] ; Louise Papillon-Ferland [Canada] ; Sarah Elsayed [Canada] ; Peter E. Wu [Canada] ; Kiran Battu [Canada] ; Sandra Porter [Canada] ; Babak Rashidi [Canada] ; Robyn Tamblyn [Canada] ; Louise Pilote [Canada] ; James Downar [Canada] ; Andre Bonnici [Canada] ; Allen Huang [Canada] ; Todd C. Lee [Canada] ; Emily G. Mcdonald [Canada]COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.
001728 (2020) Michael H. Gollob [Canada]COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm.
001851 (2020) Janet Sultana [Italie] ; Paola Maria Cutroneo [Italie] ; Salvatore Crisafulli [Italie] ; Gabriele Puglisi [Italie] ; Gaetano Caramori [Italie] ; Gianluca Trifir [Italie]Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines.
001976 (2020) Brenner Elías Sabando Vélez [Équateur] ; Carlos Plaza Meneses [Équateur] ; Miguel Felix [Équateur] ; Emanuel Vanegas [Équateur] ; Valeria L. Mata [Équateur] ; Horacio Romero Castillo [États-Unis] ; Jorge W. Oliveros Alvear [Équateur] ; Enrique Bolo A [Équateur] ; Maria Alejandra Posligua [Équateur] ; Luis Renato Layedra Bardi [Équateur] ; Carlos Vera Paz [Équateur] ; Ivan Cherrez-Ojeda [Équateur]A practical approach for the compassionate use of convalescent plasma in patients with severe COVID-19 in developing countries.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Patient Selection" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Patient Selection" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Patient Selection
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021